26.9 C
New York
Saturday, July 26, 2025

Tag: suppliers

Grupo Bafar Reports Second quarter 2025 Results

CHIHUAHUA, México, July 25, 2025 (GLOBE NEWSWIRE) -- Grupo Bafar, S.A.B. de C.V. (BIVA: BAFARB), a leading and benchmark company in the national food sector, announced its results for the second quarter of 2025, highlighting sustained growth driven by innovation, digitalization, and expansion strategies across all its divisions.

ASI Show Chicago 2025 Draws Nearly 5,000 Promo Pros to McCormick Place

TREVOSE, Pa., July 25, 2025 /PRNewswire/ -- The Advertising Specialty Institute® (ASI), the leading authority in the $26.6 billion promotional products industry, today announced...

Best Kratom? Super Speciosa Relaunches Enhanced Watermelon Kratom Tincture in 2025

As Consumer Demand Surges for Lab-Tested Botanical Products, Super Speciosa Responds With a Timely Tincture Update and GMP-Backed Transparency
As Consumer Demand Surges for Lab-Tested Botanical Products, Super Speciosa Responds With a Timely Tincture Update and GMP-Backed Transparency

FILM & TAPE EXPO 2025: Asia’s Leading Functional Film and Adhesive Tape Show Returns to Shenzhen, Featuring Sustainability and Innovation.

SHENZHEN, China, July 25, 2025 /PRNewswire/ -- FILM & TAPE EXPO 2025, Asia's premier B2B expo for functional film and industrial adhesive tapes, will...

Davis Commodities Evaluates Stablecoin Licensing and ESG Tokenization Frameworks Amid Growing Momentum in Regulated Digital Finance

Davis Commodities explores stablecoin licensing and ESG tokenization to align with evolving regulations and $10T tokenized asset growth.

Davis Commodities Reviews Bitcoin Reserve Model and Tokenized ESG Infrastructure Amid $16 Trillion Digital Asset Surge

Davis Commodities reviews Bitcoin reserves and tokenized ESG assets, targeting $16T RWA market with blockchain-driven capital strategies.

Gentex Reports Second Quarter 2025 Financial Results

ZEELAND, Mich., July 25, 2025 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today reported financial results for the three and six months ended June 30, 2025.

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

NEW YORK and MAINZ, GERMANY, July 25, 2025Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The adaptation is based on the recommendation from the EMA’s Emergency Task Force (ETF) to update COVID-19 vaccines to target the LP.8.1 variant for the 2025-2026 season. The ETF stated that “targeting LP.8.1 will help maintain the effectiveness of the vaccines as SARS-CoV-2 continues to evolve.”2

LG Energy Solution Releases 2025 Second-Quarter Financial Results

LG Energy Solution posts KRW 5.6 trillion in consolidated revenue and KRW 492.2 billion in operating profit in Q2 2025The company records quarterly operating...

Hammond Power Solutions Reports Second Quarter 2025 Financial Results

(Dollar amounts are in thousands, in Canadian currency unless otherwise specified)

Coca-Cola Consolidated Reports Second Quarter and First Half 2025 Results

(1) Volume is measured on a standard physical case basis and is used to standardize differing package configurations delivered via direct store delivery.

SouthState Corporation Reports Second Quarter 2025 Results, Declares an Increase in the Quarterly Cash Dividend

WINTER HAVEN, Fla., July 24, 2025 /PRNewswire/ -- SouthState Corporation ("SouthState" or the "Company") (NYSE: SSB) today released its unaudited results of operations and...

Ammunition Depot Celebrates Ninth Circuit Victory – Awaiting Final Court Mandate

BOCA RATON, Fla., July 24, 2025 /PRNewswire/ -- Ammunition Depot, a leading nationwide supplier of ammunition, firearms, and tactical gear, is proud to announce...

Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit

MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs)
MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs)

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSuppliers